2022 Phase 1 Recruitment Outlook in Australia:
Strategies for Recruiting Success in the Covid-Normal Market.
This webinar will discuss the recruitment outlook for Phase 1 clinical trials in Australia in the new Covid-normal world. Investing heavily in extensive data analysis and research, hear how Nucleus Network has developed an innovative recruitment approach underpinned by key strategies and additional infrastructure to enhance recruitment.
Register to hear discussions covering the stabilized participant market, the introduction of satellite sites to access a broader population of participants, and more than 18 months of new participant market education. Data and current recruitment trends will be examined to provide the audience with a better understanding of the current and future Australian market and the innovative strategies being deployed to ultimately ensure that as the country transitions to open borders, Australia continues to remain a destination of choice for the conduct of Phase 1 clinical trials.
Presented by Nucleus Network’s Charlotte Hall – Chief Operating Officer; Mari Ericksen – Director of Marketing; and Bryanna McDermott – Director of Project Management this webinar will provide biotech and pharma clients a valuable recruiting outlook for Australia in 2022, as the world transitions into a post-pandemic normal market.